EMPROVING outcomes: Evaluating the effect of an ultralung protective strategy for patients with ARDS treated with ECMO.
April A GrantAmit BadiyeChristina MehtaZiyue WuMichael KoernerRodrigo ViannaMatthias LoebeAli GhodsizadPublished in: Journal of cardiac surgery (2020)
Failing to protect the lungs with a lung protective strategy such as the EMPROVE protocol after ECMO cannulation was associated with mortality. For every 1 mm Hg increase in the mean PIP, the odds of dying increased 1.4 times, and for every 1% increase in the mean FiO2 , the odds of dying increased 1.16 times. For lung rest to truly be effective, the lungs must be relieved of the burden of gas exchange.
Keyphrases
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- palliative care
- respiratory failure
- mechanical ventilation
- randomized controlled trial
- risk factors
- cardiovascular events
- room temperature
- type diabetes
- cardiovascular disease
- newly diagnosed
- fluorescent probe
- intensive care unit
- single molecule
- weight loss
- aqueous solution